BioSpace News Archive

– Conference Call Today at 4:30 p.m. ET – Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees options to purchase an aggregate of 333,000 shares of BioCryst common stock on February 28, 2020 as inducements material to each employee entering into employment with BioCryst.

BD, a leading global medical technology company, announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2020, at 10:45 a.m. ET..

Science Applications International Corp. (NYSE:SAIC) was awarded approximately $1.1 billion in national security contracts during the fourth quarter of fiscal year 2020, bringing the annual total in this category to $2.8 billion.

Alpine Immune Sciences Announces Cancellation of Presentation and Webcast at the Cowen 40 th Annual Healthcare Conference

Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), today announced an update to its previously announced financial results for the three months and full year ended December 31, 2019.

KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced that it has submitted a New Drug Application (NDA) under Section 505(b)(2)

43% of Americans Believe Impact a Bigger Threat to the Economy Than People’s Health and Generally Not Prepared for Significant Spread

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the year ended December 31, 2019. “

Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty-five cents ($0.45) per share on the $.10 par value Common Stock of the corporation.